Molina Healthcare Inc (MOH) Director Daniel Cooperman Sells 4,500 Shares
Molina Healthcare Inc (NYSE:MOH) Director Daniel Cooperman sold 4,500 shares of Molina Healthcare stock in a transaction that occurred on Tuesday, November 7th. The stock was sold at an average price of $78.79, for a total transaction of $354,555.00. Following the completion of the transaction, the director now owns 9,087 shares in the company, valued at approximately $715,964.73. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
Molina Healthcare Inc (NYSE:MOH) traded down $1.45 during trading on Tuesday, hitting $77.53. 1,604,254 shares of the stock traded hands, compared to its average volume of 1,350,000. The company has a debt-to-equity ratio of 1.06, a quick ratio of 1.24 and a current ratio of 1.29. Molina Healthcare Inc has a fifty-two week low of $42.56 and a fifty-two week high of $80.65. The stock has a market cap of $4,380.00, a PE ratio of 24.59 and a beta of 0.91.
Molina Healthcare (NYSE:MOH) last posted its quarterly earnings results on Thursday, November 2nd. The company reported ($1.62) EPS for the quarter, missing the consensus estimate of $0.23 by ($1.85). Molina Healthcare had a negative net margin of 1.76% and a positive return on equity of 17.76%. The company had revenue of $5.03 billion for the quarter, compared to analysts’ expectations of $4.95 billion. During the same quarter in the prior year, the firm earned $0.85 earnings per share. The company’s revenue was up 10.7% on a year-over-year basis. research analysts anticipate that Molina Healthcare Inc will post -2.14 earnings per share for the current year.
ILLEGAL ACTIVITY WARNING: “Molina Healthcare Inc (MOH) Director Daniel Cooperman Sells 4,500 Shares” was originally published by American Banking News and is owned by of American Banking News. If you are viewing this story on another domain, it was stolen and reposted in violation of US & international copyright and trademark law. The legal version of this story can be read at https://www.americanbankingnews.com/2017/11/07/molina-healthcare-inc-moh-director-daniel-cooperman-sells-4500-shares.html.
Several institutional investors have recently bought and sold shares of MOH. LS Investment Advisors LLC grew its holdings in shares of Molina Healthcare by 40.9% during the 2nd quarter. LS Investment Advisors LLC now owns 1,829 shares of the company’s stock valued at $127,000 after acquiring an additional 531 shares in the last quarter. Meeder Asset Management Inc. purchased a new position in shares of Molina Healthcare during the 2nd quarter valued at $136,000. Riverhead Capital Management LLC grew its holdings in shares of Molina Healthcare by 64.2% during the 2nd quarter. Riverhead Capital Management LLC now owns 2,463 shares of the company’s stock valued at $170,000 after acquiring an additional 963 shares in the last quarter. Sabal Trust CO purchased a new position in shares of Molina Healthcare during the 3rd quarter valued at $206,000. Finally, Bronfman E.L. Rothschild L.P. grew its holdings in shares of Molina Healthcare by 478.7% during the 2nd quarter. Bronfman E.L. Rothschild L.P. now owns 3,316 shares of the company’s stock valued at $229,000 after acquiring an additional 2,743 shares in the last quarter. Institutional investors and hedge funds own 95.88% of the company’s stock.
Several research analysts have issued reports on the stock. Zacks Investment Research upgraded shares of Molina Healthcare from a “sell” rating to a “hold” rating in a research report on Monday. Morgan Stanley lifted their price target on shares of Molina Healthcare from $68.00 to $89.00 and gave the stock an “overweight” rating in a research report on Friday. Jefferies Group LLC lifted their price target on shares of Molina Healthcare from $64.00 to $74.00 and gave the stock a “hold” rating in a research report on Friday. Wolfe Research upgraded shares of Molina Healthcare from a “market perform” rating to an “outperform” rating in a research report on Monday, October 23rd. Finally, BMO Capital Markets assumed coverage on shares of Molina Healthcare in a research report on Monday, October 16th. They issued a “market perform” rating and a $70.00 price target on the stock. Three analysts have rated the stock with a sell rating, ten have given a hold rating and five have given a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus price target of $64.30.
About Molina Healthcare
Molina Healthcare, Inc offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The Company operates through three segments: Health Plans, Molina Medicaid Solutions and Other, which includes its Pathways Health and Community Support LLC (Pathways) business.
Receive News & Ratings for Molina Healthcare Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare Inc and related companies with MarketBeat.com's FREE daily email newsletter.